Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SimCorp A/S – Share buyback program

Company Announcement no. 29/2022On February 15, 2022 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 20.0m, to be executed during the period from February 15, 2022 to July 31, 2022. The following transactions have been executed under the program:          Date                 Number of shares

Irisity launches its new Irisity Partner Program.

Irisity AB (publ), a global provider of innovative AI-powered video analytics solutions announces its new Irisity Partner Program (IPP) for distributors, system integrators, and re-sellers.Irisity, together with its global newtwork of channel partners have deployments in more than 90 countries worldwide. Iristy aspires to strengthen its global channel network in order to offer customers the best video analytics solutions to their security challenges. The new IPP provides channel partners with essential tools in order to expand their business by selling, installing, and supporting Irisity’s

BioStock: WntResearch’s new CEO on her background and the journey ahead

Pernilla Sandwall took over the helm as the new CEO of development company WntResearch a little more than a month ago. She joins the company during a very interesting time, ahead of interim results from the phase II study NeoFox that are expected in the fourth quarter. BioStock has spoken to Pernilla to find out more about her background and to get her view on the journey ahead.Read the full article at biostock.se:https://www.biostock.se/en/2022/06/wntresearchs-new-ceo-on-her-background-and-the-journey-ahead/This is a press release from BioStock - Connecting Innovation & Capital. https:/

Jonas Caspari Bark New CFO at Realheart

Press release 27 June, 2022 Realheart has recruited Jonas Caspari Bark as its new Chief Financial Officer. He joins Realheart from a similar position with Ecokraft Sverige AB and has previously, among other things, worked in various roles within the ABB group. Jonas Caspari Bark starts on August 5.Realheart is a Swedish company, headquartered in Västerås, that is developing the world's first artificial four-chamber heart. The company has recently taken several important steps forward, not least in leaving the prototype behind and now testing the clinical version of the heart in animal

70 years since the Helsinki Olympics – the Fazer Experience Visitor Centre revisits the buzz of the 1952 Summer Games

Fazer has always been involved in great moments in Finnish history, and the Helsinki 1952 Olympic Games are no exception. The Summer Olympics held in 1952 were a one-of-a-kind undertaking for Finland, and Fazer was a visible part of the enormous effort. Now, the Fazer Experience Visitor Centre is celebrating the 70th anniversary of the Games with a mini exhibition prepared in collaboration with Tahto (the Sports Museum of Finland). Objects from the Olympics will be exhibited from 20 June to 15 August 2022.“In many ways, the Helsinki 1952 Olympic Games were a watershed moment in Fazer’s

poLight ASA signs a Proof-of-Concept agreement with a top tier medical customer

Horten, 27 June 2022 - poLight ASA (OSE: PLT) today announced that the company has signed an agreement to support a phased PoC (Proof of Concept) endoscopic camera system development with an unnamed top tier medical device customer.  The total fee value of this POC agreement is approximately NOK 1.700.000 and is expected to be received across four phases between Q3 2022 and 1[st] half of 2023.  The customer’s intention is to apply the resulting camera design into a mass production project. “Medical endoscope market can potentially become an important growth segment for us, so we’re very

Basware updates its full year EBIT guidance for 2022 based on the one-off expenses related to the tender offer from Sapphire BidCo Ltd

Basware Corporation, inside information, 27 June 2022 at 10:05 a.m. EESTBasware updates its full year EBIT guidance for 2022 following the announcement of the final result of the voluntary recommended public cash tender offer from Sapphire BidCo Ltd for all the shares in Basware Corporation and their confirmation for executing the transaction. The company updates its EBIT guidance due to one-off expenses related to the tender offer. The respective one-off expenses are mainly driven by transaction advisory fees. The company expects its order intake and net sales to develop in line with the

Heat for 1300 households from Denmark's first PtX agreement

Fredericia, Denmark, 27 June 2022 - TVIS and Everfuel succeed Denmark’s first agreement of surplus heat from a PtX facility. Everfuel invests in a 4.5 MW heat pump to cool the supporting processes in the hydrogen production. TVIS, the local district heating network,  is building a 1.2 kilometre long transmission line to Everfuel's 20 MW electrolysis plant, HySynergy. When TVIS and Everfuel signed the first agreement six months ago the volume corresponded to the consumption in 5-600 households per year. The new agreement increases the volume to about three times as much, as the volume of

Tobii Dynavox empowers people with ALS to create their own synthetic voice within minutes

Tobii Dynavox , the world leader in assistive technology for communication, announces that it releases a new voice banking integration within its speech-generating software TD Talk , available immediately. Using Acapela Group’s solution My Own Voice , people with conditions such as ALS can easily capture their own unique voice, to create a personalized synthetic voice and use it directly in TD Talk.  For individuals diagnosed with ALS or other conditions resulting in speech

Final result of Sapphire BidCo Ltd’s voluntary public cash tender offer for all the shares in Basware Corporation: Sapphire BidCo Ltd completes the tender offer

Basware Corporation, stock exchange release, 27 June 2022 at 10:00 a.m. EESTNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. On 26 April 2022, Sapphire BidCo Ltd (the “Offeror”) commenced a voluntary recommended public cash tender offer to acquire all of the issued and outstanding shares in Basware Corporation (“Basware” or the “Company”) that are not held by Basware or any of

CEO Comment June 2022 – Several Accomplishments & Positive Progress

It’s been a busy and eventful first half of 2022, so I just want to share some thoughts with you as we head into full summer. The fact is that a lot of positive things are happening in the company:  · Actiste[®] is being used in Qatar with the aim to improve the lives of people living with diabetes. · Actiste[®] is being used for clinical research by diabetes patients in the United Kingdom.  · We are getting closer to commercialization in the United Arab Emirates where a number of healthcare facilities have signed up for participation in the upcoming user pilot initiated

Invitation to Immunovia’s Presentation of PanFAM-1 Results

LUND (SWEDEN) – Immunovia will present PanFAM-1 results today, June 27, 2022 at 13:00 pm CET. Analysts, investors and media are invited to a webcast and teleconference. The presentation slides will be available at www.immunovia.com. See also press release published: https://investor.immunovia.com/panfam-1-results-partly-inconclusive/   Philipp Matieu, CEO and President, Thomas King, Medical Director, and Jeff Borcherding, CEO US operations, will present. The presentation will be held in English and be followed by a Q&A session. You are welcome to join via webcast or phone, see details

Sandvik to acquire PCD tools manufacturer Frezite

Sandvik has signed an agreement to acquire 100% of the equity interests of the Portugal-based company Frezigest, SGPS (“Frezite”). Frezite’s offering primarily consists of made-to-order polycrystalline diamond (PCD) tools for metal and wood applications, with exposure to the automotive, general engineering and aerospace segments. The company will be reported within Walter, a division within Sandvik Manufacturing and Machining Solutions. “With the acquisition of Frezite, we take another important step in our shift to growth strategy. We have a clear ambition for our machining solutions

East of England trusts to digitize pathology following a cloud service contract with Sectra

Linköping, Sweden – June 27, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract for digital pathology with East Suffolk and North Essex NHS Foundation Trust and West Suffolk NHS Foundation Trust in the UK. The solution will enable pathologists to review and collaborate around cases in a way that is not possible with microscopes. This will reduce variation and increase efficiency in primary diagnostics, thereby improving cancer care.The two NHS trusts in the East of England will transform pathology services for a

Atlas Copco to acquire a Chinese manufacturer of industrial vacuum pumps and systems

Nacka, Sweden, June 27, 2022: Atlas Copco has agreed to acquire the assets of Shandong Jinggong Pump Co., Ltd. The company develops and manufactures liquid ring vacuum pumps and systems, mainly used in the chemical and other general industries.Shangdong Jinggong Pump, which operates under the brand name Chinco, was founded in 1998 and has 100 employees. The headquarter is located in Zibo, in China’s Shandong province. In 2021, the company had revenues of approximately MUSD 12 (MSEK 102).  "Shangdong Jinggong Pump is an agile company with a strong manufacturing setup and high-quality

Musti Group plc – Managers' transactions – Rönnberg

Musti Group plc – Managers' transactions – Rönnberg Musti Group plc            Managers’ transactions                  27 June 2022, at 9.30am Musti Group Oyj - Managers’ transactions                  _________________________________________ Person subject to the notification requirement Name: David Rönnberg Position: Chief Executive Officer Issuer: Musti Group LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 16381/5/4 ____________________________________________ Transaction date: 2022-06-23 Venue: NASDAQ HELSINKI

Digia and Productivity Leap join forces to create the preconditions for powerful growth, especially in the social welfare and healthcare sector

Digia has a strong foothold in the social welfare and healthcare industry, and the acquisition of Productivity Leap further strengthens Digia’s capabilities as a comprehensive digitalisation partner. The acquisition enables new growth, particularly in social welfare and healthcare, where Digia sees potential for expansion in the coming years.Press release 27 June 2022 at 9:30 a.m. EET On 27 June 2022, Digia Plc and Productivity Leap Oy signed an agreement whereby Digia purchases Productivity Leap’s entire share capital. The acquisition is planned to be completed on 1 July 2022. With the

PanFAM-1 Results Partly Inconclusive

LUND, SWEDEN – Immunovia today announced results from the PanFAM-1 study. The PanFAM-1 study is a prospective, multi-center, investigational study, designed to assess the performance of the IMMray™ PanCan-d test in early detection of pancreatic ductal adenocarcinoma (PDAC) in high-risk populations. The IMMray™ PanCan-d test met its primary endpoint of test specificity comparable to imaging in the study. Sensitivity, however, could not be evaluated due to the low number of PDACs among study participants.   “We aimed for more tangible results of the PanFAM-1 study, which are partly

Vestas to strengthen digital transformation and Development business with new organisational setup and member of Executive Management

News release from Vestas Wind Systems A/SAarhus, 27 June 2022 As the global leader in wind energy, Vestas plays a leading role in providing the solutions and services needed to accelerate the energy transition. To sustain our leading position and help governments and customers address the climate crisis and improve energy security, Vestas will strengthen our organisational focus on our Development Business and our digital transformation. To accelerate our digital transformation, we will establish a new function, Digital Solutions, with the key objective to digitally transform our

Enhertu recommended for breast cancer EU approval

27 June 2022 07:05 BST Enhertu recommended for approval in the EU by CHMP for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen Recommendation based on DESTINY-Breast03 trial results showing AstraZeneca and Daiichi Sankyo's Enhertu reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-

Paolo Guglielmini to be appointed new President and CEO for Hexagon

Hexagon AB, a global leader in digital reality solutions, combining sensors, software and autonomous technologies, today announced that Paolo Guglielmini will succeed Ola Rollén as President and CEO of Hexagon AB, effective 31 December 2022. Gun Nilsson has decided to step down as CEO for Hexagon’s principal shareholder MSAB on 1 October and consequently leave her position as Chairman of Hexagon AB at the Annual General Meeting (AGM) 2023. MSAB, in consultation with Hexagon’s nomination committee, has the intention to propose Ola Rollén as new Chairman of the Board at the AGM 2023.

ProtOnART – a new consortium for proton online adaptive radiation therapy

A new consortium for the advancement of Proton Online Adaptive Radiation Therapy, ProtOnART, uniquely brings together researchers, clinicians, and industry. The members of the ProtOnART consortium are OncoRay in Dresden, Germany, and PARTICLE in Leuven, Belgium, both combining academic expertise with clinical experience in proton therapy, as well as industrial partners Ion Beam Applications (IBA), proton therapy system manufacturer from Belgium, and RaySearch Laboratories, provider of oncology software solutions from Sweden.ProtOnART builds upon the partners’ long-standing research efforts

Metso Outotec launches Planet Positive Filtration Plant Units for sustainable performance

Metso Outotec Corporation’s press release on June 27, 2022, at 09:00 a.m. EESTMetso Outotec is launching a comprehensive Filtration Plant Units offering to maximize operational reliability in different types of dewatering applications where superior process performance combined with energy and water efficiency is required. The offering consists of three major plant units around Metso Outotec’s Larox® PF and Larox® FFP, and Metso Outotec CC filter technologies, all designed for the dewatering of concentrates and tailings. The latest addition to the offering is the Larox® FFP3716 Filter

Peab completely renovates Rimnervallen Stadium in Uddevalla

Peab has been commissioned to renovate Rimnersvallen Stadium to meet standards for parasport, Swedish Championships in track and field and Superettan in soccer. The stadium will also be completely accessibility adapted for athletes and the public. The customer is Uddevalla Municipality and the contract is worth SEK 211 million.During the spring Peab has worked on planning the project and preparatory groundwork. The project is now going into production which entails building new stands for around four thousand spectators and four lighting towers and taking measures to handle settlement

There are no items matching the current filter
There are no more items matching the current filter
Back to top